A novel role for α‐viniferin in suppressing angiogenesis by blocking the VEGFR‐2/p70S6K signaling pathway

Angiogenesis plays important roles in pathological conditions such as cancer and inflammation as well as normal tissue development and homeostasis. Here, we investigated the effects and molecular mechanisms of α‐viniferin, an oligostilbene isolated from Caragana sinica, on human umbilical vein endothelial cell responses in vitro and angiogenic sprouting in aortic rings ex vivo. α‐viniferin treatment inhibited mitogen‐induced HUVEC proliferation by retinoblastoma protein hypophosphorylation. In addition, α‐viniferin suppressed mitogen‐induced HUVEC adhesion, migration, invasion, and microvessel outgrowth. These anti‐angiogenic activities of α‐viniferin might be mediated through downregulation of cell cycle‐related proteins, vascular endothelial growth factor receptor‐2 (VEGFR‐2), and matrix metalloproteinase‐2. Furthermore, inactivation of VEGFR‐2/p70 ribosomal S6 kinase signaling pathway was found to be involved in α‐viniferin‐mediated modulation of endothelial cell responses. Our results demonstrate the pharmacological functions and molecular mechanisms of α‐viniferin in regulating angiogenesis, suggesting the therapeutic potential of α‐viniferin to treat and prevent various angiogenesis‐related diseases. Anti‐angiogenic activity of α‐viniferin.